Iitri - performance area 1 TO2 performance area i-management and operations support
Active Awarded Last action
- Contract number
- 75N95024F00001
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5 Part of Illinois Institute Of Technology
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $130,367
Award facts
- Contract value 50% obligated
-
- $212,495.00 Current, with exercised options
- $258,274.00 Potential, with all options
- Completion date 89% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Chicago, IL 60616, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $45,779 | |
| Exercise an Option | $84,588 | |
| Original award | $82,128 |
About this award
The National Institute on Drug Abuse awarded a firm fixed-price delivery order valued at $258,274 to IIT Research Institute (IITRI) on March 1, 2024, for Management and Operations Support under Performance Area 1. The contract is scheduled for completion by February 28, 2027, and will be performed in Chicago, Illinois. This delivery order represents work conducted under one of IITRI's larger indefinite delivery/indefinite quantity contract vehicles with the National Institutes of Health. No set-aside designation was used in this award, indicating it was competed on a full and open basis. IITRI is a non-profit contract research organization and wholly-owned subsidiary of Illinois Institute of Technology, specializing in preclinical drug development services and research support across multiple scientific and technical domains for federal agencies.
IITRI's parent organization, Illinois Institute of Technology, maintains substantial IDIQ contract vehicles totaling hundreds of millions of dollars across the NIH ecosystem, including contracts with the National Institute of Allergy and Infectious Diseases, National Center for Advancing Translational Sciences, National Cancer Institute, and National Institute of Neurological Disorders and Stroke. These vehicles support preclinical research services including toxicology studies, safety evaluations, pharmacokinetic analyses, and drug efficacy assessments. The current delivery order continues IITRI's established role as a critical resource for federal agencies conducting early-stage drug development and safety evaluation research supporting investigational new drug applications across cancer, neurological, infectious disease, and other therapeutic areas.
Quick answers
Who was awarded contract 75N95024F00001?
75N95024F00001 was awarded to IIT Research Institute by National Institute on Drug Abuse (National Institutes of Health) on March 1, 2024.
How much is contract 75N95024F00001 worth?
The government has obligated $130,367 on 75N95024F00001. Its current value, with exercised options, is $212,495. Its potential value, with all options, is $258,274.
Is contract 75N95024F00001 an order under another contract?
Yes. 75N95024F00001 is a delivery order under 75N95021D00026, an indefinite delivery contract.
Was contract 75N95024F00001 competed?
The extent of competition for 75N95024F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award